MAPT and Alzheimer disease: Alzheimer disease (AD) is a neurodegenerative disease characterized by extracellular Aβ plaques and intracellular neurofibrillary tangles of hyperphosphorylated tau protein.31 Impaired lymphatic clearance could significantly contribute to the accumulation of these neurotoxic proteins, triggering the chronic neuroinflammation observed in AD.